Respiratory Syncytial Virus
CDC shortens 5-day COVID isolation, updates guidance on masks and testing in new 2024 recommendations
Health
The Centers for Disease Control and Prevention announced Friday that it would wind down much of its remaining guidance specifically targeted at ...
High-risk patients alarmed by CDC’s plan to ease covid isolation guidance
Health
Concerns among medically vulnerable people are growing as the Centers for Disease Control and Prevention prepares to drop its long-standing recommendation that those with ...
Health officials are monitoring a triple threat of respiratory illnesses. Here’s how to avoid getting sick
Health
As the new year gets underway, health officials are issuing a nationwide alert about a triple threat: The simultaneous spread of the ...
Monitor symptoms and stay home to avoid spread as flu, COVID cases climb
Health
Between flu, COVID and RSV cases, area hospitals are experiencing a busy start to the new year. Hundreds of patients have sought ...
RSV, flu, COVID, stomach virus cases all rising in NJ
Health
2-minute read What is RSV? Here’s what we know about RSV vaccines and drugs. What to know about new drugs and vaccines ...
US health officials say flu cases rise while RSV may be peaking
Health
NEW YORK (AP) — Flu is picking up steam while RSV lung infections that can hit kids and older people hard may ...
Explainer-What do we know about China’s respiratory illness surge?
Science
By Andrew Silver SHANGHAI (Reuters) – A request by the World Health Organization for more information on a surge in respiratory illnesses ...
WHO asks China for details on respiratory illness outbreaks
Science
(Reuters) – The World Health Organization (WHO) on Wednesday officially requested that China provide detailed information on an increase in respiratory illnesses ...
First flu deaths of 2023-24 season reported in North Carolina, health officials urge vaccination
Health
WLOS — Two adults in the western part of North Carolina died due to complications of influenza in October, marking the first ...
GSK RSV vaccine shows potential to protect adults 50 to 59
Business
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical ...
